TeDia - A Telemedicine-Based Treatment Model for Inpatient and Interprofessional Diabetes Care.
diabetes
inpatient care
telemedicine
Journal
Diabetes, metabolic syndrome and obesity : targets and therapy
ISSN: 1178-7007
Titre abrégé: Diabetes Metab Syndr Obes
Pays: New Zealand
ID NLM: 101515585
Informations de publication
Date de publication:
2019
2019
Historique:
received:
05
09
2019
accepted:
25
10
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
11
12
2019
Statut:
epublish
Résumé
The proportion of hospitalized patients with diabetes as a secondary diagnosis increases continuously. Therefore, we have developed a team-based interprofessional and telemedicine-based diabetes management system named TeDia ("Telemedical Diabetology") and implemented it in an inpatient setting. The aim of the retrospective real-world study was to show the clinical impact of TeDia following its implementation. TeDia is characterized by an interpersonal and telemedicine-based exchange of hospital routine data between specially trained nurses ("diabetes managers") and external diabetologists. It was implemented in three acute hospitals of the Düsseldorf Catholic Hospital Group in Düsseldorf, Germany. Clinical awareness of diabetes, diabetes-related complications and diagnosis-related group (DRG)-based revenues were analyzed using ICD routine coding. Furthermore, the frequency of HbA1c determinations as well as hospitalization days were investigated. Before (2010), during (2012) and after the implementation of TeDia (2014), the number of patients with ICD coding for diabetes, decompensated diabetes, diabetic neuropathy, diabetic nephropathy as well as complicated diabetes increased by +18%, +93%, +101%, +113% and +89%, respectively. Using the same DRG grouper, revenues increased by +53% (from 27 (2013) to 42 (2014) DRG points). Frequency of HbA1c determinations rose by +85%, whereas the time for an average length of stay decreased by -12% (-0, 91 days) in comparison to patients without diabetes. TeDia improved clinical awareness for diabetes and its complications. This new treatment model increased revenues and reduced hospital days indicating enhanced treatment quality. Our findings emphasize the necessity of novel technologies in inpatient settings for the improvement of efficacy, safety and efficiency of diabetes care.
Identifiants
pubmed: 31819573
doi: 10.2147/DMSO.S229933
pii: 229933
pmc: PMC6890178
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2479-2487Informations de copyright
© 2019 Röhling et al.
Déclaration de conflit d'intérêts
Dr Kerstin Kempf reports personal fees from Verlag Kirchheim GmbH & Co. KG, outside the submitted work; Prof. Dr. Stephan Martin reports grants from Sanofi Aventis, during the conduct of the study. The authors report no other conflicts of interest in this work.
Références
Diabet Med. 2015 Oct;32(10):1361-7
pubmed: 25865087
Curr Diab Rep. 2017 Sep 14;17(10):98
pubmed: 28913745
Pharmacotherapy. 2008 Apr;28(4):421-36
pubmed: 18363526
Clin Lab. 2004;50(9-10):599-607
pubmed: 15481636
Diabet Med. 2013 Dec;30(12):1393-402
pubmed: 23875546
Prev Chronic Dis. 2009 Apr;6(2):A59
pubmed: 19289002
Intern Med J. 2010 Jul;40(7):521-6
pubmed: 20633061
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001271
pubmed: 15846614
J Interprof Care. 2005 Oct;19(5):444-51
pubmed: 16308168
Diabetes Educ. 2002 Jul-Aug;28(4):590-8
pubmed: 12224199
Curr Diab Rep. 2017 Sep;17(9):70
pubmed: 28726156
Diabetes Educ. 2014 Nov-Dec;40(6):797-805
pubmed: 25253624
Am J Manag Care. 2013 May;19(5):421-30
pubmed: 23781894
Ann Pharmacother. 2007 Oct;41(10):1569-82
pubmed: 17712043
Curr Diab Rep. 2015 Jun;15(6):608
pubmed: 25948497
Diabetes Care. 2016 May;39(5):772-9
pubmed: 26953170
Diabetologia. 2003 Feb;46(2):182-9
pubmed: 12627316
Diabetes Care. 2017 Apr;40(4):509-517
pubmed: 28325798
Diabet Med. 2015 Jul;32(7):951-7
pubmed: 25781644
Ann Fam Med. 2005 May-Jun;3(3):209-14
pubmed: 15928223
Front Pharmacol. 2015 Aug 11;6:167
pubmed: 26321953
J Interprof Care. 2014 Nov;28(6):568-9
pubmed: 24828621
Ann Intern Med. 2017 May 2;166(9):621-627
pubmed: 28346946
Exp Clin Endocrinol Diabetes. 2018 Feb;126(2):123-129
pubmed: 28750430
Diabetes Care. 2013 Dec;36(12):4091-7
pubmed: 24170754
Cochrane Database Syst Rev. 2018 Jul 16;7:CD001271
pubmed: 30011347
Diabetes Res Clin Pract. 2014 Feb;103(2):206-17
pubmed: 24300019
PLoS One. 2014 Nov 17;9(11):e113154
pubmed: 25402347
J Diabetes Complications. 2015 Nov-Dec;29(8):1177-82
pubmed: 26355027
J Gen Intern Med. 2004 May;19(5 Pt 1):466-71
pubmed: 15109346
Popul Health Metr. 2014 May 07;12:12
pubmed: 24904239
BMJ. 2012 Jun 21;344:e3874
pubmed: 22723612
Diabetes Care. 2017 Jul;40(7):863-871
pubmed: 28500214
Curr Diabetes Rev. 2019;15(2):133-140
pubmed: 29357807
Diabetes Care. 2010 Aug;33(8):1872-94
pubmed: 20668156
PLoS One. 2019 Oct 11;14(10):e0223159
pubmed: 31603900
BMJ. 2002 Apr 6;324(7341):819-23
pubmed: 11934775
Am J Med. 2016 Feb;129(2):139-42
pubmed: 26522798